The Agency for Health Care Policy and Research last week announcedplans to evaluate the safety and clinical value of FDG-PET fordiagnosing and managing epilepsy. The review will center on the use of FDG-PET to locate thefocus of epileptic seizures for
The Agency for Health Care Policy and Research last week announcedplans to evaluate the safety and clinical value of FDG-PET fordiagnosing and managing epilepsy.
The review will center on the use of FDG-PET to locate thefocus of epileptic seizures for possible surgical excision. Radiologistsat the University of California at Los Angeles and elsewhere havereported good results with this application since at least 1993.
The evaluation was requested by the Health Care Financing Administrationand will influence whether Medicare coverage will be extendedfor the procedure.
New Study Assesses Long-Term Outcomes of PSMA PET Use in PCa Recurrence Cases
October 24th 2024For patients with biochemical recurrence of prostate cancer, PSMA PET imaging may facilitate a 12.8 percent lower incidence of prostate cancer mortality in contrast to the combination of CT and bone scan, according to long-term outcome estimates from a new decision-analytic modeling study.
Can Diffusion MRI Predict Patient Response to Neoadjuvant Chemotherapy for Breast Cancer?
October 23rd 2024A model emphasizing time-dependent diffusion MRI was 15 percent more effective than apparent diffusion coefficient (ADC) measurements at predicting pathologic complete response to neoadjuvant chemotherapy for women with breast cancer, according to new research.